Assessment of Transcultural Psychotherapy in Child Major Depressive Disorder
NCT ID: NCT04206969
Last Updated: 2025-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2020-10-28
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Transcultural psychotherapy is an original psychotherapeutic technique developed to meet these specific requirements in France and in different European and American countries. Its theoretical and methodological foundations rest on the works of George Devereux in ethnopsychiatry (1970). A psychotherapeutic technique intended for first-generation migrants was developed by Tobie Nathan and coll (1986). Marie-Rose Moro and colleagues (1990) have adapted this technique to second-generation migrants.
Indicated as a second-line treatment after the failure of standard management, this technique is fully formalized today. It comprises group consultations for the child and the family as a one-hour session each month, directed by a principal therapist, assisted by a group of co-therapists (of diverse cultural origins and occupations) and an interpreter in the family's mother tongue. The concept of culture is used to establish the therapeutic alliance, decode the symptoms, and propose treatment.
The children and adolescents receiving this treatment have varied psychopathological profiles, mostly involving depressive and/or anxiety disorders. Specifically, migrants' children are especially vulnerable to depression, their psychiatric care is generally longer and less effective than in the general population, and their rate of treatment failure higher.
Transcultural psychotherapy has demonstrated its value in these situations in numerous qualitative studies, but its efficacy has not yet been assessed by a method providing a high level of evidence, such as randomized controlled trials.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
European Comparative Effectiveness Research on Internet-based Depression Treatment
NCT02542891
Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents
NCT04182061
Internet-Delivered Cognitive Behaviour Therapy for Adolescent Depression
NCT02363205
Neural Mechanisms of Family-Focused Treatment for Youth Depression
NCT06289010
An Internet-based Program for Prevention and Early Intervention of Adolescent Depression
NCT02780232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcultural psychotherapy
In addition to usual care, the participants in the treatment group receive transcultural psychotherapy in the inclusion centers, which consists of 5 sessions every 7 weeks (W6, W13, W20, W27, and W34). During all the research process, participants from both groups continue their usual care provided by the referent medical team outside the inclusion center.
Transcultural psychotherapy
In addition to usual care, the participants receive transcultural psychotherapy
standard care
usual care provided by the referent medical team
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcultural psychotherapy
In addition to usual care, the participants receive transcultural psychotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be a first or second-generation migrant (born abroad or born from at least one parent who is born abroad)
* Have a psychological and/or psychiatric follow-up by a first-line care
* Have been referred for transcultural psychotherapy by their first line care to treat depression resistant to standard management.
* Present a depression according to the clinician who proposes the transcultural treatment (first line therapist), based on usual as well as cultural symptoms criteria of the below list:
* Sadness
* Diminish interest or pleasure in most of the usual activities
* Insomnia or hypersomnia
* Psychomotor agitation
* Asthenia, loss of energy
* Feeling of worthlessness or excessive guilt
* Recurrent throughs of death
* School problems (school failure, drop in grades, aggressivity with adult, school refusal…)
* Mutism, and selective mutism
* Runaways
* Aggressivity
* Impulsivity
* Violence and delinquency
* Conflicts with parents and adults from the community
* Exclusion from family
* Somatic pains
* Massive separation anxiety
* Regressive symptoms - loosing of an already acquired function such as speech, walk, stay alone for a sufficient time in relation to age, manage stress or anxiety for reasonable situations…
* Denial of medical care for a chronic disease with no evident reasons
* Cultural designation such as possessed by a spirit, being a child witch, or other cultural designations
* State of trance The list is not exhaustive, and some other symptoms may be accepted if the first line clinician as well as the referent agree. The patients will be well characterized after inclusion.
* Present a score \>= 4 on the iCGI - Severity at inclusion.
* Present transcultural issues confirmed by the referent (usual procedure of indirect pre-selection based on the presentation of the situation by referring physician)
* Have an informed consent signed by both parents/ one parent / tutor / adult patient (cf. 14.1 paragraph)
Exclusion Criteria
* Patient presents an acute psychiatric disorder which hinders the realization of the transcultural therapy - for example, excited delirium with great psychic disorganization, or high suicidal risk patients. These situations will be excluded during the screening time based on the first line therapist evaluation
* Patient presents an acute somatic disease which may hinder the well organization of the therapy
* Patient addressed for a legal expertise
* Child's/Adolescent's refusal
* Pregnant or breastfeeding (for women for young women of childbearing age)
* Participation in another interventional study
* Patient under guardianship or curatorship
6 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan LACHAL, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Psychopathologie de l'enfant, de l'adolescent, CHU Avicenne
Bobigny, , France
Service de psychiatrie de l'enfant et de l'adolescent, CHRU Gabriel Montpied
Clermont-Ferrand, , France
Maison de Solenn, Cochin Hospital
Paris, , France
Centre Médico-psychologique, Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital La Grave, CHU Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01830-57
Identifier Type: OTHER
Identifier Source: secondary_id
P180601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.